STOCK TITAN

IMMUTEP (PRRUF) Financials

PRRUF OTC
FY2025 annual
Revenue $6.8M +29.7% YoY
Net Income -$40.4M n/m YoY
EPS (Diluted) -$0.03 n/m YoY
Free Cash Flow -$40.8M n/m YoY
Market Cap $24.8M as of Oct 22, 2026
Price / Sales 3.6x on $6.8M revenue, FY2025
Price / Earnings n/m net loss, so no earnings multiple, FY2025
Price / Book 0.3x on $94.4M equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 22, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (20-F/6-K) Latest period FY2025, ended Jun 30, 2025 Reported Currency USD FYE June

Newest figures come from the 20-F for FY2025, filed Oct 24, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PRRUF SEC filings page.

IMMUTEP LTD (PRRUF) reported $6.8M in revenue for fiscal year 2025, up 29.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score not available

IMMUTEP LTD does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
1/7

IMMUTEP LTD passes 1 of 7 computable financial strength tests (2 of the nine could not be computed from available data). No profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) passes.

Earnings Quality No Cash Backing
N/A

IMMUTEP LTD reported a net loss of $40.4M while operations used $40.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$6.8M
YoY+29.7%
5Y CAGR-9.8%

IMMUTEP LTD generated $6.8M in revenue in fiscal year 2025. This represents an increase of 29.7% from the prior year.

Net Income
-$40.4M
YoYn/m
5Y CAGRn/m

IMMUTEP LTD reported a net loss of $40.4M in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.

EPS (Diluted)
-$0.03
YoYn/m
5Y CAGRn/m

IMMUTEP LTD earned -$0.03 per diluted share (EPS) in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$40.8M
YoYn/m
5Y CAGRn/m

IMMUTEP LTD recorded an outflow of $40.8M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. The change from the prior year is not meaningful, because that figure was zero or negative.

Cash & Debt
$44.3M
YoY-59.0%
5Y CAGR+19.6%

IMMUTEP LTD held $44.3M in cash as of fiscal year 2025; no long-term debt figure is on record for that period.

Shares Outstanding
1.46B
YoY+0.5%
5Y CAGR+24.5%

IMMUTEP LTD had 1.46B shares outstanding in fiscal year 2025. This represents an increase of 0.5% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Return on Equity
-42.8%
YoY-20.2pp
5Y change-2.3pp

IMMUTEP LTD's ROE was -42.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 20.2 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Net Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$32.7M
YoY+55.7%
5Y CAGR+25.0%

IMMUTEP LTD invested $32.7M in research and development in fiscal year 2025. This represents an increase of 55.7% from the prior year.

Capital Expenditures
$30K
YoY+54.2%
5Y CAGR+17.7%

IMMUTEP LTD invested $30K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 54.2% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

PRRUF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PRRUF annual income statement
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-F
Revenue$6.8M+29.7%$5.2M+51.1%$3.5M-25.7%$4.7M+56.9%$3.0M-73.8%$11.4M+116.7%$5.2M-3.5%$5.4M+67.9%$3.2M+114.9%$1.5M
R&D Expenses$32.7M+55.7%$21.0M+9.5%$19.2M+9.7%$17.5M+94.2%$9.0M-16.1%$10.7M+11.2%$9.7M+30.6%$7.4M+28.0%$5.8M+10.1%$5.2M
Interest Expense$24K+19.3%$20K+50.3%$14K-78.7%$64K+766.6%$7K+2.2%$7Kn/m$0N/AN/A$6K
Income Tax$0n/m$0n/m$0-100.0%$23-5.1%$25-3.0%$26n/m$0-100.0%$1Kn/m-$566Kn/m-$878K
Net Income-$40.4Mn/m-$28.5Mn/m-$26.6Mn/m-$22.2Mn/m-$22.4Mn/m-$9.3Mn/m-$12.9Mn/m-$9.4Mn/m-$7.2Mn/m-$46.1M
EPS (Basic)-$0.03n/m-$0.02n/m-$0.03n/m-$0.03n/m-$0.04n/m-$0.02-$3.71n/m-$3.43-$0.31n/m-$2.07
EPS (Diluted)-$0.03n/m-$0.02n/m-$0.03n/m-$0.03n/m-$0.04n/m-$0.02-$3.71n/m-$3.43-$0.31n/m-$2.07
Diluted Shares (Avg)1.46B+21.2%1.20B+34.6%892M+5.1%849M+42.7%595M+44.1%413M347M+26.1%275M2.37B+6.4%2.23B

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, SG&A Expenses, Operating Income, EBITDA.

PRRUF Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PRRUF annual balance sheet
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-F
Total Assets$103.2M-23.3%$134.6M+37.0%$98.2M+39.3%$70.5M+14.7%$61.5M+91.4%$32.1M+13.0%$28.4M-18.3%$34.8M+29.6%$26.8M-15.1%$31.6M
Current Assets$98.0M-23.3%$127.8M+42.1%$89.9M+43.4%$62.7M+22.3%$51.3M+138.8%$21.5M+30.1%$16.5M-22.1%$21.2M+73.4%$12.2MN/A
Cash & Equivalents$44.3M-59.0%$108.0M+31.4%$82.2M+48.9%$55.2M+21.6%$45.4M+150.3%$18.1M+56.2%$11.6M-33.1%$17.4M+84.9%$9.4M-39.5%$15.5M
Accounts Receivable$6.5M+32.2%$4.9M-7.4%$5.3M-8.4%$5.8M+25.9%$4.6M+102.2%$2.3M-37.6%$3.6M+43.4%$2.5M+50.8%$1.7MN/A
Goodwill$4.7M-14.0%$5.5M-13.0%$6.3M-13.2%$7.3M-24.3%$9.6M-8.1%$10.5M-11.8%$11.9M-12.4%$13.6M-7.1%$14.6M-5.8%$15.5M
Total Liabilities$8.8M+9.0%$8.1M+10.0%$7.3M+30.9%$5.6M-14.9%$6.6M-28.4%$9.2M-19.0%$11.3M+13.5%$10.0M+54.1%$6.5M+20.3%$5.4M
Current Liabilities$8.4M+19.8%$7.0M+7.5%$6.5M+47.0%$4.4M+10.6%$4.0M+72.6%$2.3M-37.6%$3.7M+30.3%$2.9M+41.1%$2.0MN/A
Non-Current Liabilities$387K-63.1%$1.0M+30.4%$805K-30.5%$1.2M-54.8%$2.6M-62.6%$6.8M-10.0%$7.6M+6.8%$7.1M+59.9%$4.5MN/A
Total Equity$94.4M-25.4%$126.5M+39.2%$90.9M+40.0%$65.0M+18.3%$54.9M+139.3%$23.0M+34.3%$17.1M-31.1%$24.8M+21.8%$20.4M-22.4%$26.2M
Retained Earnings-$291.9Mn/m-$255.5Mn/m-$226.5Mn/m-$208.8Mn/m-$205.9Mn/m-$190.0Mn/m-$183.8Mn/m-$181.0Mn/m-$178.0MN/A

Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments, Long-Term Debt.

PRRUF Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PRRUF annual cash flow statement
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-F
Operating Cash Flow-$40.8Mn/m-$23.3Mn/m-$23.6Mn/m-$20.9Mn/m-$13.2Mn/m-$7.5Mn/m-$10.7Mn/m-$5.8Mn/m-$6.5Mn/m-$8.4M
Capital Expenditures$30K+54.2%$20K-64.6%$55K+248.4%$16K+35.3%$12K-12.3%$13K-54.1%$29K+230.0%$9K+72.5%$5K-74.7%$20K
Free Cash Flow-$40.8Mn/m-$23.3Mn/m-$23.6Mn/m-$20.9Mn/m-$13.2Mn/m-$7.5Mn/m-$10.7Mn/m-$5.8Mn/m-$6.5Mn/m-$8.4M
Investing Cash Flow-$25.3Mn/m-$14.0Mn/m-$55Kn/m-$16Kn/m-$12Kn/m-$13Kn/m-$29Kn/m-$9Kn/m-$5K-106.7%$76K
Financing Cash Flow-$345K-100.5%$63.6M+25.5%$50.7M+45.8%$34.7M-12.0%$39.5M+179.8%$14.1M+151.3%$5.6M-58.8%$13.6Mn/m-$7K-100.0%$19.1M

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Dividends Paid, Share Buybacks.

PRRUF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PRRUF annual financial ratios
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-F
Net Margin-594.6%-545.0%-767.2%-476.6%-753.6%-81.6%-244.9%-173.3%-221.9%-3056.6%
Return on Equity-42.8%-20.2pp-22.5%+6.7pp-29.2%+5.0pp-34.2%+6.6pp-40.8%-0.4pp-40.5%+34.8pp-75.2%-37.2pp-38.0%-2.7pp-35.3%+140.3pp-175.6%
Return on Assets-39.1%-17.9pp-21.2%+5.9pp-27.1%+4.5pp-31.5%+4.9pp-36.4%-7.6pp-28.9%+16.4pp-45.3%-18.1pp-27.1%-0.3pp-26.8%+118.9pp-145.7%
Current Ratio11.69-6.6x18.25+4.4x13.81-0.3x14.16+1.3x12.81+3.6x9.26+4.8x4.44-3.0x7.43+1.4x6.05N/A
Liabilities-to-Equity0.090.0x0.060.0x0.080.0x0.090.0x0.12-0.3x0.40-0.3x0.66+0.3x0.40+0.1x0.32+0.1x0.20
Asset Turnover0.070.0x0.040.0x0.040.0x0.070.0x0.05-0.3x0.35+0.2x0.180.0x0.160.0x0.12+0.1x0.05
FCF Margin-601.0%-444.6%-681.5%-447.7%-444.9%-65.8%-204.7%-105.9%-201.7%-558.8%

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Debt-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin, FCF Margin.

Frequently Asked Questions

What is IMMUTEP LTD's annual revenue?

IMMUTEP LTD (PRRUF) reported $6.8M in total revenue for fiscal year 2025. This represents a 29.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is IMMUTEP LTD's revenue growing?

IMMUTEP LTD (PRRUF) revenue grew by 29.7% year-over-year, from $5.2M to $6.8M in fiscal year 2025.

Is IMMUTEP LTD profitable?

No, IMMUTEP LTD (PRRUF) reported a net loss of $40.4M in fiscal year 2025.

IMMUTEP LTD (PRRUF) reported diluted earnings per share of -$0.03 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

IMMUTEP LTD (PRRUF) has a return on equity of -42.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

IMMUTEP LTD (PRRUF) recorded an outflow of $40.8M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

IMMUTEP LTD (PRRUF) recorded an outflow of $40.8M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

IMMUTEP LTD (PRRUF) had $103.2M in total assets as of fiscal year 2025, including both current and long-term assets.

IMMUTEP LTD (PRRUF) invested $30K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

IMMUTEP LTD (PRRUF) invested $32.7M in research and development during fiscal year 2025.

IMMUTEP LTD (PRRUF) had 1.46B shares outstanding as of fiscal year 2025.

IMMUTEP LTD (PRRUF) had a current ratio of 11.69 as of fiscal year 2025, which is generally considered healthy.

IMMUTEP LTD (PRRUF) had a liabilities-to-equity ratio of 0.09 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

IMMUTEP LTD (PRRUF) had a return on assets of -39.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

IMMUTEP LTD (PRRUF) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $24.8M as of Oct 22, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

IMMUTEP LTD (PRRUF) trades at 3.6x sales, its market capitalization divided by $6.8M revenue, FY2025. The market capitalization is $24.8M as of Oct 22, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

IMMUTEP LTD (PRRUF) has a Piotroski F-Score of 1 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

IMMUTEP LTD (PRRUF) reported a net loss of $40.4M while operations used $40.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top